Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2014

Dec 29, 2014

30583_dirs_2014-12-29_e0cc5a09-476c-4f4a-b084-4d59529e9079.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-12-24

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-24 Common Stock M 3000 $12.99 Acquired 46195 Indirect
2014-12-24 Common Stock S 3000 $88.7310 Disposed 43195 Indirect
2014-12-24 Common Stock S 2000 $88.7310 Disposed 227157 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-24 Stock Option (right to buy Common Stock) $12.99 M 3000 Disposed 2016-05-10 Common Stock (3000) Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (10000) 10000 Indirect
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (10000) 10000 Indirect
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (10000) 10000 Indirect
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (10000) 10000 Indirect
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (20000) 20000 Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed November 6, 2014

F2: The reporting person an his spouse act as trustees for the Bienaime Family Trust

F3: The price in column 4 is an average weighted price. The price actually received ranged from $87.00 to $89.41. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.

F4: Original option grant vests 6/48ths on November 11, 2006, and 1/48th on the 11th of every month thereafter.

F5: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

F6: The reporting person's spouse is the trustee of each child's trust.